Aspartate 496 from the subsite S2 drives specificity of human dipeptidyl peptidase III by Abramić, Marija et al.
Biol. Chem. 2015; 396(4): 359–366
*Corresponding author: Marija Abramić, Division of Organic 
Chemistry and Biochemistry, Ruder Bošković Institute, Bijenička 
cesta 54, P.O. Box 180, HR-10002 Zagreb, Croatia,  
e-mail: abramic@irb.hr
Zrinka Karačić, Maja Šemanjski, Bojana Vukelić and Nina Jajčanin-
Jozić: Division of Organic Chemistry and Biochemistry, Ruder 
Bošković Institute, Bijenička cesta 54, P.O. Box 180, HR-10002 
Zagreb, Croatia
Short Communication
Marija Abramić*, Zrinka Karačić, Maja Šemanjski, Bojana Vukelić and Nina Jajčanin-Jozić
Aspartate 496 from the subsite S2 drives 
specificity of human dipeptidyl peptidase III
Abstract: Human dipeptidyl peptidase III (hDPP III) is 
a member of the M49 metallopeptidase family, which is 
involved in intracellular protein catabolism and oxidative 
stress response. To investigate the structural basis of hDPP 
III preference for diarginyl arylamide, using site-directed 
mutagenesis, we altered its S2 subsite to mimic the coun-
terpart in yeast enzyme. Kinetic studies revealed that the 
single mutant D496G lost selectivity due to the increase 
of the Km value. The D496G, but not S504G, showed sig-
nificantly decreased binding of peptides with N-terminal 
arginine, and of tynorphin. The results obtained identify 
Asp496 as an important determinant of human DPP III 
substrate specificity.
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Human dipeptidyl peptidase III (DPP III; EC 3.4.14.4) is 
a constituent of the human central proteome (Burkard 
et al., 2011), and a member of the M49 family of metallo-
peptidases (DPP III family), which catalyze the hydrolytic 
cleavage of dipeptides from the amino termini of their 
oligopeptide substrates (Abramić et al., 2004a; Chen and 
Barrett, 2004; Rawlings et al., 2012). These zinc-depend-
ent enzymes are considered to be implicated in intracel-
lular protein catabolism, oxidative stress response, and, 
in mammals, opioid peptides degradation (Abramić et al., 
1988; Fukasawa et al., 1998; Baršun et al., 2007; Liu et al., 
2007). Human DPP III is also related to pathological pro-
cesses of cataractogenesis and tumor growth (Zhang 
et al., 2001; Šimaga et al., 2003). It is a monomeric protein 
with 737 amino acids in the polypeptide chain. Crystal 
structure of ligand-free human and yeast DPP III has 
been solved, revealing elongated protein molecule with 
two domains separated by a wide cleft, and very similar 
overall fold (Baral et  al., 2008; Bezerra et  al., 2012). We 
have recognized five evolutionary conserved regions in 
the primary structure of M49 peptidases, embedded in a 
stretch of about 300 amino acids (Abramić et al., 2004a), 
which in human DPP III starts with Gly313 (Figure 1).
The first 3-D structure of human DPP III inactive 
mutant E451A in complex with pentapeptide tynorphin 
revealed the formation of closed enzyme’s active site 
during the substrate binding, due to the domain move-
ment (Bezerra et al., 2012). The same crystal structure has 
exposed the amino acid residues forming five deep sub-
sites (S2 to S3′), consisting of seven (S2′) to 13 (S2) residues.
Most recently, we have found that yeast and human 
enzyme differ significantly in specificity towards dipep-
tidyl arylamide substrates of X-Arg-arylamide type, and 
in catalytic efficiency (Jajčanin-Jozić and Abramić, 2013). 
The yeast counterpart was found to be less active catalyst 
with broader specificity.
To investigate the underlying structural basis of 
human DPP III preference for Arg-Arg-arylamide, a hall-
mark substrate of this type of mammalian tissue dipepti-
dyl peptidase (Ellis and Nuenke, 1967), we compared the 
amino acid sequence of human and yeast enzyme (non-
selective towards dipeptidyl naphthylamides) by multiple 
sequence alignment (MSA). Interestingly, we found iden-
tity in structurally equivalent residues forming the S1, S1′ 
and S2′ subsites, and a significant difference in two, out of 
13, constituents of the S2 subsite: in human DPP III Asp496 
and Ser504 correspond to Gly505 and Gly 513 in the yeast 
enzyme (Jajčanin-Jozić and Abramić, 2013). There was a 
difference in S3′ subsite constituents as well, but rather 
conservative (Ile422, Arg675, and Phe677 in yeast are 
replaced by structurally equivalent Val412, Lys670, and 
Ile672 in human DPP III). As the dipeptidyl arylamide 
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Figure 1 Conserved regions in human dipeptidyl peptidase III 
(DPP III).
Five evolutionary conserved regions of the M49 family are  presented 
as black areas (R1 to R5) in the 3-D structure of ligand-free human 
DPP III (PDB: 3FVY). Structure was generated using PyMOL (www.
pymol.org). The zinc ion is represented as a white sphere.
substrates occupy the subsites S2, S1 and S1′, in this study, 
we focused to the structural variation observed in the S2 
subsite. We assumed that the observed difference in sub-
strate specificity of human and yeast DPP III originates in 
a single mutation of Asp496 to Gly, or Ser504 to Gly, or 
in double mutation of both Asp496 and Ser504 to glycine. 
To prove our hypothesis, we prepared single mutant pro-
teins of human DPP III, D496G, and S504G, and a double 
mutant D496G/S504G by site-directed mutagenesis, and 
examined their properties.
The structural characteristics of purified recombi-
nant mutant proteins were examined through the circular 
dichroism (CD) analysis and compared to the wild-type 
DPP III. Almost identical CD spectra were obtained 
(Figure 2), suggesting that the substitution of Asp496 or 
Ser504, or both Asp496 and Ser504, with a glycine residue 
did not cause a change in protein secondary structure.
Hydrolytic activity of the purified mutated enzymes 
was examined towards three dipeptidyl 2-naphthylamide 
substrates differing in the amino acid residue in P2 posi-
tion (Arg-Arg-2NA, Ala-Arg-2NA, and Phe-Arg-2NA), and 
compared to the wild-type. All mutant proteins were enzy-
matically active. The single mutant S504G exhibited very 
similar kinetic properties to the wild-type: pronounced 
preference for Arg-Arg-2NA, due to the significantly lower 
Km value for that substrate (Table 1). Catalytic efficiency 
(kcat/Km) of S504G was somewhat (20%–40%) higher for 
Arg-Arg-2NA and Ala-Arg-2NA, as compared to the wild-
type human DPP III (Table 1).
In contrast to the replacement of Ser504, the substi-
tution of Asp496 with glycine residue dramatically influ-
enced the specificity, but not the hydrolytic activity, of 
mutated enzyme. The Km values for all three X-Arg-2NA 
were significantly changed in D496G: 11-fold increased Km 
for Arg-Arg-2NA, and 6-fold and 4.8-fold lowered Km values 
for Ala-Arg-2NA and Phe-Arg-2NA, respectively. The kcat 
values for the hydrolysis of these substrates by D496G did 
not change (Table 1).
A double mutant’s D496G/S504G kinetic properties 
for the hydrolysis of Ala-Arg- and Phe-Arg-2NA, and the Km 
value for Arg-Arg-2NA, were almost identical to that of the 
single mutant D496G. The only difference between these 
two enzyme forms was that the double mutant D496G/
S504G, but not D496G, displayed a significantly (2-fold) 
lower kcat value, compared to the wild-type (Table 1). The 
double mutant was omitted from further investigation.
The results obtained with dipeptidyl 2-naphthylamide 
substrates pointed to the Asp at the position 496 as the 
residue critical for human DPP III substrate specificity. We 
further investigated whether the Asp496 is the basis for the 
greater preference of human DPP III for peptide substrates 
with a basic residue at P2. Interaction with peptides was 
assayed at physiological pH (7.4). Polypeptide aprotinin 
(58 amino acids) was chosen as its sequence starts with 
an Arg. The Ki values were determined using Arg-Arg-2NA 
(with the wild-type and S504G) or Phe-Arg-2NA (with the 
wild-type and D496G) as an alternative substrate. There-
fore, at first, the Km values were determined at pH 7.4 for 
the corresponding synthetic substrates and the wild-type 
and both single mutants.
As shown in Table 2, the affinities (Ki values) of the 
wild-type human DPP III and S504G for selected peptides 
were very similar: the highest affinity was determined for 
pentapeptide tynorphin (Ki about 4 nm), followed by the 
heptapeptide angiotensin III (wild-type DPP III Ki = 21 nm). 
Notably, both these enzyme forms showed affinity in 
micromolar concentration range for polypeptide apro-
tinin, which was comparable to that shown for penta-
peptide Leu-enkephalin (Table 2). However, the mutant 
with replaced Asp496, D496G, differed significantly. Its 
binding potency was 10-fold lower for angiotensin III (Ki 
value of 208 nm) and 12.6-fold decreased for aprotinin 
(Ki = 148 μm), and almost 40-fold reduced for tynorphin. 
Interestingly, the Ki value for another pentapeptide, Leu-
enkephalin, was almost unchanged, compared to the 
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Figure 2 Circular dichroism (CD) spectra of wild-type human dipeptidyl peptidase III and mutants (D496G, S504G, and D496G/S504G).
CD spectra were recorded on a Jasco J-815 spectropolarimeter (JASCO, Easton, MD, USA). Purified enzyme solutions (0.3–0.5 mg protein/ml) 
were measured in 20 mm sodium phosphate buffer, pH 7.4.
wild-type enzyme. A small decrease (1.9-fold) in D496G 
affinity was observed for tripeptide Arg-Phe-Ala (Table 2).
In search of submolecular determinants of distinct 
substrate specificity of human DPP III towards diargi-
nyl arylamide, we started from our finding that yeast 
enzyme is non-selective in this respect (Jajčanin-Jozić and 
Abramić, 2013) and the fact that human and yeast DPP III 
proteins have a very similar fold. The three-dimensional 
structure of a human DPP III inactive variant (E451A) – 
tynorphin (Val-Val-Tyr-Pro-Phe) complex (Bezerra et  al., 
2012) enabled definition of enzyme subsites S2–S3′. The S2 
subsite of human DPP III is formed by 13 residues, major-
ity belonging to the evolutionary conserved regions (R) 
of M49 family (Figure 1): Glu316 (R1), Ile390 (R2), Asn391 
(R2), Ile392 (R2), Asn394 (R2), Asp396 (R2), Arg399 (R2), 
His455 (R3), Trp495, Asp496, Ser504, Glu507 (R4), and 
Glu508 (R4).
Considering the constituents of the subsites that 
accommodate dipeptidyl arylamide substrate, that is, 
those building the S2, S1 and S1′ subsite, human and yeast 
DPP III differ only in two amino acid residues from the 
subsite S2 (Asp496 and Ser504 in human are structurally 
equivalent to Gly505 and Gly513 in yeast enzyme, respec-
tively). By the application of site-directed mutagenesis, we 
have altered the S2 subsite of human DPP III to mimic its 
counterpart in yeast enzyme. Kinetic studies revealed that 
already single mutant D496G has lost selectivity for Arg-
Arg-2NA, a well-known preferred substrate of human (and 
mammalian) DPP III (Table 1). This was due to the change 
of Km value (observed for all three X-Arg-2NA examined), 
indicating that Asp496 is crucial for human DPP III speci-
ficity towards diarginyl arylamide substrate. According to 
the obtained results, Ser504 would not be important for 
selectivity of human DPP III with this type of substrate.
Interestingly, the double mutant with substituted both 
Asp496 and Ser504 by Gly showed 3-fold lower catalytic 
efficiency towards Arg-Arg-2NA than the single mutant 
D496G which indicates that Ser504 has a role in obtaining 
the full catalytic activity of human DPP III.
It is known that the yeast ortholog is much less effec-
tive catalyst for the hydrolysis of dipeptidyl arylamides 
than the human enzyme (Jajčanin-Jozić and Abramić, 
2013). The double mutant’s catalytic efficiency towards 
Arg-Arg-2NA is 24-fold lower compared to the human DPP 
III wild-type, but 16-fold higher than the yeast enzyme 
(Jajčanin-Jozić and Abramić, 2013). This indicates that, 
except the difference in the constituents of the S2 subsite, 
there are some other, yet unknown, determinants that 
govern yeast DPP III catalytic power.
Significant influence of one amino acid residue from 
the substrate binding site on the enzyme specificity is not 
rare phenomenon in the field of peptidases. The S2-P2 
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Table 1 Kinetic analysis of human dipeptidyl peptidase III (DPP III) enzyme variants.
Wild-type D496G S504G D496G/S504G
Arg-Arg-2NA
 Km (μm) 3.7±1.1 41.3±15.3 3.9±1.0 42.2±9.1
 kcat (s-1) 21.5±2.1 30.5±8.3 33.5±4.5 10.4±1.8
 kcat/Km (mm-1 s-1) 5810.8 738.5 8589.7 246.4
Ala-Arg-2NA
 Km (μm) 100.9±3.0 16.5±5.0 106.8±11.7 22.7±12.2
 kcat (s-1) 14.3±1.1 10.1±1.3 25.0±0.5 10.7±1.8
 kcat/Km (mm-1 s-1) 141.7 612.1 234.1 471.4
Phe-Arg-2NA
 Km (μm) 20.9±5.2 4.4±0.2 21.7±1.4 6.2±0.4
 kcat (s-1) 8.0±3.7 4.2±1.1 8.7±3.0 4.2±0.2
 kcat/Km (mm-1 s-1) 382.8 954.5 400.9 677.4
Km and kcat values are the averages of three determinations±SD. Experimental procedures: the construct containing full cDNA for human DPP 
III with affinity C-terminal six-histidine tag (His6) was cloned into pET-21a vector (Novagen), between NdeI and XhoI restriction sites, accord-
ing to procedure described by Špoljarić et al. (2011). Point mutations of the human DPP III gene: D496G and S504G were carried out with 
the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA), using the pET-21a-hDPP III-His6 construct as a template 
and the primers, custom synthesized by Sigma (St. Louis, MO, USA): D496G forward primer: 5′-GGA GCG GGG AGA CCT GGG GTA GCA AGT 
TCA GCA CC-3′; D496G reverse primer: 5′-GGT GCT GAA CTT GCT ACC CCA GGT CTC CCC GCT CC-3′; S504G forward primer: 5′-GTT CAG CAC CAT 
CGC CGG TAG CTA CGA AGA GTG CCG G-3′; S504G reverse primer: 5′-CCG GCA CTC TTC GTA GCT ACC GGC GAT GGT GCT GAA C-3′. The double 
mutant D496G/S504G was obtained by performing site-directed mutagenesis using D496G primers on the pET-21a-DPPIIIHisS504G vector 
as a template. Each mutant sequence was confirmed by DNA sequencing of the entire DPPIII gene (Macrogen sequencing service, Amster-
dam, The Netherlands). The wild-type human DPP III and all mutant enzymes (D496G, S504G, D496G/S504G) were expressed in Escherichia 
coli as recombinant proteins containing an C-terminal His6-tag and purified by metal affinity chromatography. Heterologous expression 
was performed according to Špoljarić et al. (2011) with minor modifications. Constructs containing His-tagged human DPP III, wild-type or 
mutants, were īntroduced by electroporation into the E. coli expression strain BL21-CodonPlus(DE3)-RIL (Stratagene) grown in Luria-Bertani 
broth with ampicillin (Fermentas, St. Leon-Rot, Germany) (100 μg/ml), and induction of protein expression was carried overnight using 0.5 
mm IPTG (isopropyl β-D-1-thiogalactopyranoside, Fermentas) at 18°C. Cell harvesting and lysis, and protein purification from the soluble 
fraction of the cell lysate, by metal affinity chromatography, was performed according to established procedure (Jajčanin-Jozić et al., 2010). 
Protein purity was confirmed by gel electrophoresis under denaturing conditions, SDS-PAGE, performed on a Mini-PROTEAN Tetra System 
(Bio-Rad, Hercules, CA, USA). Protein bands were stained with Coomassie Brilliant Blue R-250 (Serva, Heidelberg, Germany). SDS-PAGE 
demonstrated that the wild-type and mutant proteins appeared as bands with similar molecular mass of about 82 kDa (not shown). Protein 
concentration was determined, using the bovine serum albumin (Serva) as a standard, following the Bradford method (Bradford, 1976). 
Fractions of high purity (according to the SDS-PAGE and the enzymatic activity) were pooled, desalted and stored as described (Špoljarić 
et al., 2011). The standard assay of enzyme activity of the human DPP III wild-type and protein variants was performed, to follow protein 
purification, with Arg-Arg-2-naphthylamide as substrate spectrophotometrically as described (Abramić et al., 2004b). Kinetic analysis was 
performed at 25°C and at pH 8.0, in the presence of 50 μm CoCl2, with the dipeptidyl 2-naphthylamides (Arg-Arg-2NA, Ala–Arg-2NA and Phe-
Arg-2NA, products of Bachem, Bubendorf, Switzerland) as substrates, by continuous measurement of the fluorescence of the free 2-naph-
thylamine, a product of enzymatic hydrolysis, as described (Abramić et al., 2004b). The kinetic parameters Km and kcat were determined 
from the initial reaction rates using Hanes plots (Jajčanin-Jozić et al., 2010) and a nonlinear regression program (GraphPad Prism version 5; 
GraphPad, La Jolla, CA, USA).
site interactions largely determine the primary specific-
ity of papain-like proteinases papain family of cysteine 
peptidases). Interestingly, Brömme et  al. have shown 
that a single mutation in the S2 subsite of these cysteine 
peptidases, which is defined by six amino acid residues 
and commonly displays preference for occupation by a 
bulky hydrophobic side chain, can change their specific-
ity (Brömme et al., 1994). Thus, the replacement of Phe205 
of cathepsin S with its cathepsin B equivalent Glu, results 
in the enzyme form that efficiently hydrolyzes substrates 
containing a basic P2 residue. Cathepsin B differs from 
cathepsin S exactly by the ability to hydrolyze such basic 
substrates. Additional evidence of the importance of one 
amino acid residue for the variation in substrate specific-
ity of papain family peptidases has provided the study of 
Chan et al. (1999). These authors altered Gly234 at the S2 
subsite of the Leishmania major cathepsin B-like protease, 
to Glu, which is found at the corresponding site in mam-
malian cathepsin B. This substitution shifted the Leishma-
nia enzyme specificity towards that of cathepsin B.
The importance of one amino acid residue for substrate 
specificity has also been shown for the representatives of 
several metallopeptidase families: aminopeptidase B (M1 
family) (Pham et  al., 2011), thimet oligopeptidase, and 
neurolysin (M3 family) (Oliveira et al., 2003; Kadonosono 
et al., 2008). In the M4 family (thermolysin-like proteases, 
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TLPs), the S1′ pocket has been demonstrated as a major 
determinant of the substrate specificity. TLPs exhibit a 
preference for large hydrophobic P1′ residues (Leu or Phe). 
However, the differences in specificity and activity exist 
between the individual members (e.g., TLP from Bacillus 
stearothermophilus prefers Phe over Leu at the P1′ posi-
tion of its dipeptide and tripeptide substrates in contrast 
to thermolysin, TLN), and the site-directed mutagenesis 
of one of the S1′ subsite residues (Phe133 substituted by 
Leu) converted the catalytic characteristics of this variant 
into that of TLN (S1′ subsite of TLN is composed of the side 
chains of Phe130, Leu133, Val139 and Leu202) (de Kreij 
et al., 2000).
Our present results on the kinetics of dipeptidyl aryla-
mides hydrolysis implied the important role of Asp496 in 
the preferential binding of the basic amino acid residue 
from the N-terminus of the substrate. To test this, we 
examined the interaction of the wild-type human DPP 
III and both single mutants with four biologically active 
peptides and a tripeptide Arg-Phe-Ala. Replacement of 
Ser504 by Gly did not influence the binding of selected 
peptides. In contrast and in accord to our prediction, the 
mutant D496G showed significantly decreased binding of 
peptides with N-terminal arginine (angiotensin III, apro-
tinin, Arg-Phe-Ala). However, this enzyme form exhibited 
dramatically lower binding (about 40-fold increased Ki 
value) of pentapeptide tynorphin (Val-Val-Tyr-Pro-Trp). 
This finding, which points to the crucial role of Asp496 in 
human DPP III interaction with tynorphin, is unexpected, 
considering that known crystal structure (Bezerra et  al., 
2012) revealed that in the direct polar interactions with 
ligand are engaged Glu316, Tyr318, Ala388, Gly389, Ile390, 
Asn391, Asn394, His568, and Arg669, but not Asp496. The 
N-terminus of the bound pentapeptide is anchored by 
Table 2 Interaction of human dipeptidyl peptidase III (DPP III) enzyme forms with peptides.
Peptide sequence (name) Ki (μm)
Wild-type D496G S504G
Arg-Val-Tyr-Ile-His-Pro-Phe (angiotensin III) 0.021±0.003 0.208±0.031 0.011±0.002
Arg-Phe-Ala 17.02±0.12 31.9±2.12 n.d.
Arg-Pro-Asp-Phe-Cys-Leu... (aprotinin, 58 amino acids) 11.72±2.36 147.70±3.51 7.40±0.55
Val-Val-Tyr-Pro-Trp (tynorphin) 0.0043±0.0002 0.1600±0.0064 0.0041±0.0004
Tyr-Gly-Gly-Phe-Leu (Leu-enkephalin) 4.32±0.40 2.23±0.14 2.89±0.26
All peptides were pure substances obtained from Bachem (Bubendorf, Switzerland), composed of L-amino acids; aprotinin was purchased 
from ThermoFisher Scientific (Waltham, MA, USA). The Ki values, which are presented as mean±standard deviation, were determined 
according to Chu and Orlowski (1985). The hydrolysis of 5 μm substrate (Arg-Arg-2NA with S504G and the wild-type DPP III, Km values: 3 μm 
and 6 μm, respectively; Phe-Arg-2NA with D496G, Km value: 9 μm) in 20 mm Tris-HCl buffer pH 7.4 in the presence and absence of peptide 
was followed at 25°C, and the Ki value was calculated as described by Baršun et al. (2007). Km for each dipeptidyl-2NA was determined 
under the same pH and temperature conditions, and was calculated from the initial reaction rates using a nonlinear regression program 
(GraphPad Prism version 5; GraphPad, La Jolla, CA, USA). n.d., not determined.
Figure 3 Asp496-Ser317 distance in human dipeptidyl peptidase III 
complex with tynorphin (PDB: 3T6B).
Structure was generated using PyMOL (www.pymol.org). Amino acid 
residues (Asp496, Ser317, and Glu316) are given by the ball-and-
stick representation. The bound peptide (tynorphin, Val-Val-Tyr-Pro-
Trp) is shown as (red) lines.
polar interactions to the side chains of Glu316 and Asn394, 
and to the main-chain carbonyl group of Asn391 (Bezerra 
et al., 2012, Figure 2C).
To explain the importance of Asp496 in binding of 
tynorphin, we inspected the crystal structure of human 
DPP III-tynorphin complex (PDB entry: 3T6B) and found 
that the oxygen of Asp496 carboxylate is 9 Å apart from 
the N-terminal nitrogen of Val 1 of tynorphin. However, 
the same carboxylate oxygen is within the hydrogen 
bond distance (3.15 Å) with the hydroxyl oxygen of Ser317 
(Figure 3). This serine is a neighboring residue to Glu316, 
which forms crucial polar interaction with the N-terminus 
of tynorphin (Figure 3).
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Therefore, the contribution of Asp496 to the binding 
of small amino acid residues (Val in tynorphin, Ala in Ala-
Arg-2NA) could be exerted indirectly, through H-bonding 
interaction with Ser317. The absence of this interaction 
(like in D496G) could influence the positioning of Glu316, 
an evolutionary conserved residue of the S2 subsite, which 
is essential for the binding of the terminal amino-group 
of the substrate. Interestingly, in the ligand-free (open 
state) human DPP III (PDB entry: 3FVY), Asp496 (residue 
from the «upper» domain) and Ser317 (residue from the 
«lower» domain) are 25.31 Å apart (Supplementary Figure 
1). Bezerra et al. (2012) have revealed that an exceptionally 
large domain motion (rotation of about 60°) occurs upon 
ligand binding to human DPP III whereby the N-terminus 
of the bound peptide tynorphin is completely buried by 
the enzyme. The domain movement brings Asp496 close 
to Ser317, and this is proven by crystal structure determi-
nation (Bezerra et al., 2012).
It is logical to anticipate that Asp496, as one of 13 
residues forming the S2 subsite (being situated deeper in 
the S2 subsite) could interact directly through polar inter-
action with the N-terminal basic residue (e.g., arginine 
in angiotensin III). Having in mind the complexity of S2 
subsite, bulkier hydrophobic P2 residues of the substrate 
(like Tyr in Leu-enkephalin), compared to Val from tynor-
phin, could form greater number of direct interactions 
with other amno acid residues – constituents of the S2 
subsite. This could explain the lack of Asp496 influence 
on binding of Leu-enkephalin to human DPP III.
To examine our hypothesis that Asp496-Ser317 inter-
action significantly contributes to the high affinity of 
human DPP III for tynorphin, we have prepared the human 
DPP III mutant S317A by the site-directed mutagenesis, as 
is described in the legend to Table 1, by using the primers 
5′-CAT CGG GTT CAT CGA GGC GTA CCG CGA CCC CTT 
TGG (forward) and 5′-CCA AAG GGG TCG CGG TAC GCC 
TCG ATG AAC CCG ATG (reverse), and affinity purified the 
recombinant protein. The kinetic parameters for hydroly-
sis of Arg-Arg-2NA, and the Ki values for peptide binding 
were determined at pH 7.4 and at 25°C. As expected, the 
substitution of Ser317 with Ala did not change the kinetic 
parameters (Km = 7.5±0.6 μm; kcat = 5.0±0.07 s-1), nor the affin-
ity for peptides with basic residue at P2 position (the Ki 
values of 17.4±0.6 nm and 20.3±4.4 μm were determined 
for angiotensin III and aprotinin, respectively). However, 
this mutant exerted identical high affinity (Ki = 3.8±0.8 
nm) interaction with tynorphin as the wild-type (Table 2). 
Therefore, we conclude that the significant contribution of 
Asp496 in tynorphin binding to human DPP III does not 
depend on the H-bonding interaction Asp496-Ser317. In the 
crystal structure of enzyme-peptide complex, this aspartic 
acid residue faces towards tynorphin, and its substitu-
tion by Gly can influence change to the size and polarity 
of this binding pocket with a concomitant change to the 
substrate binding. Therefore, further studies by computa-
tional approach and/or by the determination of the mutant 
D496G-tynorphin complex crystal structure are needed to 
obtain a valid answer to this intriguing question.
There are many examples of the importance of one 
particular aspartic acid residue for the catalytic activity 
and/or substrate specificity of an enzyme. Apart from Asp 
being a part of the catalytic triad of serine peptidases, 
among the proteolytic enzymes, the classical paradigm is 
Asp189, situated at the base of the S1 substrate binding 
pocket of trypsin, a residue critical for this enzyme’s 
specificity for Arg and Lys in P1 position of its substrates 
(Evnin et al., 1990).
In the M49 family, there is no evolutionary conserved 
aspartic acid residue, and only one conserved Glu, at the 
position 316 in the sequence of human DPP III. Our results 
reveal Asp496, a constituent of S2 subsite, as important 
structural determinant of human DPP III substrate speci-
ficity and give the guidance for further investigation of the 
family M49.
The S2 subsite is of crucial importance for substrate 
binding and hydrolytic activity of M49 peptidases. Eluci-
dation of the X-ray structure of human DPP III in complex 
with pentapeptide tynorphin identified that the N-ter-
minus of the bound peptide is completely buried by the 
enzyme and anchored by polar interactions to the three 
conserved constituents of the S2 subsite – the side chains 
of Glu316 and Asn394 and to the main-chain carbonyl 
group of Asn391 (Bezerra et al., 2012). It is known that DPP 
III does not accept peptides with modified amino-end as 
substrates (Abramić et al., 1988).
The majority of S2 constituents are situated in the 
evolutionary conserved regions of the M49 family, and 
Asp496, Trp495, and Ser504 are not. Based on the MSA of 
16 DPP III amino acid sequences (including four bacterial) 
selected to cover a broad phylogenetic range (Supplemen-
tary Figure 2), Asp496 is found conserved in the major-
ity (7/12) of eukaryotic orthologs, and replaced by Ser (in 
roundworm Caenorhabditis elegans, protozoan parasite 
Giardia intestinalis and starlet sea anemone Nematostella 
vectensis) or Gly (in Aspergillus niger and Saccharomyces 
cerevisiae). MSA revealed that Trp495 is conserved in eight 
eukaryotic proteins, and substituted by Tyr in the remain-
ing four eukaryotic sequences. Instead of Ser504 (con-
served in 12 sequences, three bacterial among them), a 
Cys, Asn, or Gly are found in identical sequence position.
Due to the lack of data on prokaryotic DPP III 3-D struc-
ture, and the gaps introduced by the MSA (Supplementary 
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Figure 2), it is difficult to predict if structurally equiva-
lent Asp (or Glu) exists in the S2 subsite of prokaryotic 
orthologs. Based on the MSA alone, Bacteroides the-
taiotaomicron DPP III contains an aspartic acid residue 
(Asp465) close to the position of Asp496 in human DPP 
III (and the ortholog from Stigmatella aurantiaca does 
not), which might imply that B. thetaiotaomicron DPP III, 
similar to its human counterpart prefers Arg2-2NA as a syn-
thetic substrate. For that, we have reported experimental 
evidence (Vukelić et al., 2012).
The results obtained in our present study indicate that 
the variation of constituent of the S2 subsite, correspond-
ing to the Asp496 in human DPP III, which is observed in 
some lower eukaryotes, could influence their substrate 
specificity. As mentioned before, similar variations are 
reported for several other (metallo)peptidase families.
Interestingly, three non-conserved constituents of the 
S2 subsite of human DPP III (Trp495, Asp496, and Ser504) 
are situated in the spacer region between the evolution-
ary conserved regions R3 and R4 of the family M49. As 
we reported earlier, the length of spacer region is much 
shorter in bacterial proteins, compared to the eukaryotic 
DPPs III (Abramić et al., 2004a). The spacer region of the 
human DPP III sequence comprises linear motif E480TGE 
(Supplementary Figure 2). Hast et al. (2013) have shown 
that DPP III binds Keap 1 protein at cellular level via the 
ETGE motif, thus activating the Keap1-Nrf2 signaling 
pathway, which is very important in cellular defense to 
oxidative and electrophilic stress. No such motif is found 
in lower eukaryotic and prokaryotic DPP III sequences 
(Supplementary Figure 2), which means that DPPs III 
from different origins might vary in their physiological 
functions. The role of human DPP III in the Nrf2-Keap1 
pathway is exerted through protein-protein interactions 
and it does not require this enzyme’s activity. This sup-
ports the notion that the complete range of physiological 
functions of DPP III remains to be discovered.
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